David A. Fidock

33.6k total citations · 11 hit papers
217 papers, 17.2k citations indexed

About

David A. Fidock is a scholar working on Public Health, Environmental and Occupational Health, Computational Theory and Mathematics and Oncology. According to data from OpenAlex, David A. Fidock has authored 217 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Public Health, Environmental and Occupational Health, 51 papers in Computational Theory and Mathematics and 46 papers in Oncology. Recurrent topics in David A. Fidock's work include Malaria Research and Control (185 papers), Mosquito-borne diseases and control (71 papers) and Computational Drug Discovery Methods (51 papers). David A. Fidock is often cited by papers focused on Malaria Research and Control (185 papers), Mosquito-borne diseases and control (71 papers) and Computational Drug Discovery Methods (51 papers). David A. Fidock collaborates with scholars based in United States, United Kingdom and Switzerland. David A. Fidock's co-authors include Amar Bir Singh Sidhu, Thomas E. Wellems, Richard T. Eastman, Stephanie L. Gaw, Takashi Nomura, Dominik Verdier-Pinard, Xin Su, Paul D. Roepe, Philip J. Rosenthal and Judith Straimer and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David A. Fidock

211 papers receiving 16.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutations in the P. falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine Resistance

2000 1.1k citations David A. Fidock, Amar Bir Singh Sidhu et al. profile →
A Molecular Marker for Chloroquine-Resistant Falciparum Malaria

2001 778 citations David A. Fidock et al. profile →
Antimalarial drug discovery: efficacy models for compound screening

2004 663 citations David A. Fidock et al. profile →
Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations

2002 548 citations Amar Bir Singh Sidhu, David A. Fidock et al. Science profile →
K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates

2014 473 citations Judith Straimer, Nina F. Gnädig et al. Science profile →
Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda

2020 435 citations Aline Uwimana, Eric Legrand et al. Nature Medicine profile →
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

2009 394 citations David A. Fidock et al. profile →
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic

2017 344 citations Benjamin Blasco, Didier Leroy et al. Nature Medicine profile →
Antimalarial drug discovery: progress and approaches

2023 88 citations Jeremy N. Burrows, David A. Fidock et al. profile →
Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea

2023 70 citations Barbara H. Stokes, Marian Warsame et al. profile →
The emergence of artemisinin partial resistance in Africa: how do we respond?

2024 52 citations Aline Uwimana, David A. Fidock et al. profile →

Peers

Countries citing papers authored by David A. Fidock

Since Specialization

Citations

This map shows the geographic impact of David A. Fidock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Fidock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Fidock more than expected).

Fields of papers citing papers by David A. Fidock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Fidock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Fidock. The network helps show where David A. Fidock may publish in the future.

Co-authorship network of co-authors of David A. Fidock

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Fidock. A scholar is included among the top collaborators of David A. Fidock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Fidock. David A. Fidock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Structure–Activity Relationships of 3-Hydroxypropanamidines (HPAs) with Potent In Vivo Antimalarial Activity 2025 ·Journal of Medicinal Chemistry ·Saskia K. Klein, (unknown), Laís Pessanha de Carvalho, (unknown), (unknown), Larissa A. Meyer, (unknown), Jean‐Baptiste Thibaud, Katherine A. de Villiers, David A. Fidock, Sergio Wittlin, Matthias Rottmann, Jana Held, Bjoern B. Burckhardt, Thomas Kurz	0
2	Anti-plasmodial limonoids from Khaya anthotheca (Welw.) C.DC. 2024 ·Phytochemistry Letters ·(unknown), (unknown), Samuel Kariuki, Jeremiah Gathirwa, (unknown), (unknown), David A. Fidock, Nicholas J. Sadgrove, Moses K. Langat, Eduard Mas‐Claret, Dulcie A. Mulholland	1
3	tRNA modification reprogramming contributes to artemisinin resistance in Plasmodium falciparum 2024 ·Nature Microbiology ·Jennifer L. Small-Saunders, Ameya Sinha, (unknown), (unknown), Guangxin Sun, Peter R. Preiser, Peter C. Dedon, David A. Fidock	14
4	Plasmodium falciparum African PfCRT Mutant Isoforms Conducive to Piperaquine Resistance Are Infrequent and Impart a Major Fitness Cost 2024 ·The Journal of Infectious Diseases ·(unknown), Tomas Yeo, (unknown), Jin Yong Jeon, (unknown), Jennifer L. Small-Saunders, Sachel Mok, David A. Fidock	2
5	TKK130 is a 3-Hydroxy-Propanamidine (HPA) with Potent Antimalarial In Vivo Activity and a High Barrier to Resistance 2024 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Laís Pessanha de Carvalho, Saskia K. Klein, (unknown), (unknown), Lars Schack Kruse, Ghyslain Mombo‐Ngoma, (unknown), Jean‐Baptiste Thibaud, Katherine A. de Villiers, David A. Fidock, Bjoern B. Burckhardt, Jana Held, Sergio Wittlin, Thomas Kurz	1
6	Targeting PfCLK3 with Covalent Inhibitors: A Novel Strategy for Malaria Treatment 2024 ·Journal of Medicinal Chemistry ·(unknown), Omar Janha, (unknown), (unknown), Saumya Sharma, (unknown), Tamas Yelland, Alison J. Hole, (unknown), (unknown), (unknown), Michael J. Capper, David A. Fidock, Graeme Milligan, David J. Clarke, Andrew B. Tobin, Andrew G. Jamieson	2
7	Covalent Macrocyclic Proteasome Inhibitors Mitigate Resistance in Plasmodium falciparum 2023 ·ACS Infectious Diseases ·John M. Bennett, Kurt E. Ward, Ryan K. Muir, Stephanie Kabeche, Euna Yoo, Tomas Yeo, (unknown), Hao Zhang, Jehad Almaliti, (unknown), (unknown), Gang Lin, William H. Gerwick, Ellen Yeh, David A. Fidock, Matthew Bogyo	5
8	Keystone Malaria Symposium 2022: a vibrant discussion of progress made and challenges ahead from drug discovery to treatment 2022 ·Trends in Parasitology ·Mariko Kanai, (unknown), Elizabeth A. Ashley, Kelly Chibale, David A. Fidock	3
9	Artemisinin-resistant K13 mutations rewire Plasmodium falciparum’s intra-erythrocytic metabolic program to enhance survival 2021 ·Nature Communications ·Sachel Mok, Barbara H. Stokes, Nina F. Gnädig, Leila S. Ross, Tomas Yeo, Chanaki Amaratunga, Erik L. Allman, Lev Solyakov, Andrew R. Bottrill, Jaishree Tripathi, Rick M. Fairhurst, Manuel Llinás, Zbynek Bozdech, Andrew B. Tobin, David A. Fidock	89
10	Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials 2021 ·Trends in Parasitology ·Maëlle Duffey, Benjamin Blasco, Jeremy N. Burrows, Timothy N. C. Wells, David A. Fidock, Didier Leroy	52
11	Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda breakdown → 2020 ·Nature Medicine ·Aline Uwimana, Eric Legrand, Barbara H. Stokes, (unknown), Marian Warsame, Noella Umulisa, Daniel Ngamije, Tharcisse Munyaneza, Jean-Baptiste Mazarati, Kaendi Munguti, Pascal Campagne, Alexis Criscuolo, Frédéric Ariey, Monique Murindahabi, Pascal Ringwald, David A. Fidock, Aimable Mbituyumuremyi, Didier Ménard	435
12	Genetic screens reveal a central role for heme metabolism in artemisinin susceptibility 2020 ·Nature Communications ·Clare R. Harding, Saima Sidik, Boryana Petrova, Nina F. Gnädig, John Okombo, (unknown), Kurt E. Ward, (unknown), Elizabeth A. Boydston, David A. Fidock, Sebastian Lourido	43
13	Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance 2020 ·eLife ·(unknown), Horace Cox, Angela M. Early, Sachel Mok, Yassamine Lazrek, (unknown), María Paz Ade, Naomi W. Lucchi, (unknown), Venkatachalam Udhayakumar, (unknown), Magalie Demar, Pascal Ringwald, Daniel E. Neafsey, David A. Fidock, L. Musset	100
14	Plasmodium berghei K13 Mutations Mediate In Vivo Artemisinin Resistance That Is Reversed by Proteasome Inhibition 2020 ·mBio ·(unknown), Barbara H. Stokes, (unknown), (unknown), David A. Fidock, Andrew P. Waters	13
15	Plasmodium falciparum K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness In Vitro 2017 ·mBio ·Judith Straimer, Nina F. Gnädig, Barbara H. Stokes, (unknown), Audrey Crane, David A. Fidock	92
16	Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes 2016 ·Antimicrobial Agents and Chemotherapy ·Leonardo Lucantoni, David A. Fidock, Vicky M. Avery	46
17	K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates breakdown → 2014 ·Science ·Judith Straimer, Nina F. Gnädig, Benoît Witkowski, Chanaki Amaratunga, Valentine Duru, Arba Pramundita Ramadani, (unknown), Nimol Khim, Lei Zhang, Stephen C.-T. Lam, Philip D. Gregory, Fyodor D. Urnov, Odile Mercereau‐Puijalon, Françoise Benoit‐Vical, Rick M. Fairhurst, Didier Ménard, David A. Fidock	473
18	PfCRT and its role in antimalarial drug resistance 2012 ·Trends in Parasitology ·Andrea Ecker, Adele M. Lehane, Jérôme Clain, David A. Fidock	184
19	Gene encoding a deubiquitinating enzyme is mutated in artesunate‐ and chloroquine‐resistant rodent malaria parasites^§ 2007 ·Molecular Microbiology ·Paul Hunt, Ana Afonso, Alison M. Creasey, Richard Culleton, Amar Bir Singh Sidhu, John G. Logan, Stephanie L. Gaw, I.W. McNae, Sandra Cheesman, Virgı́lio do Rosário, Richard Carter, David A. Fidock, Pedro Cravo	127
20	Targeting Tuberculosis and Malaria through Inhibition of Enoyl Reductase 2003 ·Journal of Biological Chemistry ·Mack Kuo, Héctor R. Morbidoni, David Alland, Scott Sneddon, Brian B. Gourlie, (unknown), (unknown), Jill S. Gregory, (unknown), Christopher Yee, James M. Musser, Barry N. Kreiswirth, Hiroyuki Iwamoto, Remo Perozzo, William R. Jacobs, James C. Sacchettini, David A. Fidock	218

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact